Literature DB >> 16436404

New tobacco products: do smokers like them?

R S Caraballo1, L L Pederson, N Gupta.   

Abstract

BACKGROUND: There is little information about smokers who tried potentially reduced exposure products (PREPs) (Eclipse, Omni, Advance Lights, Accord, or Ariva), why they tried them, if they liked these products, and if they will continue to use them.
OBJECTIVES: The objectives of this qualitative study were to understand: (1) how smokers who tried PREPs learned about them, (2) reasons for first trying PREPs, (3) which PREP(s) they tried, (4) what they thought of the product at first trial, (5) reasons for continuing or discontinuing use, and (6) whether they would recommend PREPs to others.
DESIGN: In October 2002, 16 focus group sessions were conducted with current cigarette smokers aged 30-50 years: eight groups in Chattanooga, Tennessee, and eight in Dallas, Texas. Specific focus groups were composed of white men, white women, African American men, African American women, Hispanic men, or Hispanic women.
RESULTS: The majority of the participants learned about PREPs through advertising or promotion, family, friends, and co-workers; major reasons given for first trying PREPs were that the products were free or inexpensive, they wanted to stop smoking, they believed the product claims of fewer health risks, or they were curious; most of them tried Eclipse probably because the focus groups were conducted in the same cities where Eclipse was introduced; most participants did not like PREPs; most discontinued the use of PREPS, some who continued to use them did so infrequently and also kept smoking their regular brands of cigarettes; and most would not recommend PREPs, although a few might recommend them to specific groups (for example, new smokers, the young, women, curious or health conscious people).
CONCLUSIONS: Although most established smokers did not like the PREPs they tried and will not recommend them to anyone, a minority of established smokers believe that there may be a market for these products.

Entities:  

Mesh:

Year:  2006        PMID: 16436404      PMCID: PMC2563627          DOI: 10.1136/tc.2005.012856

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  18 in total

Review 1.  The dark side of marketing seemingly "Light" cigarettes: successful images and failed fact.

Authors:  R W Pollay; T Dewhirst
Journal:  Tob Control       Date:  2002-03       Impact factor: 7.552

2.  Clearing the smoke or muddying the water?

Authors:  C Bates
Journal:  Tob Control       Date:  2001-06       Impact factor: 7.552

3.  Smoker and ex-smoker reactions to cigarettes claiming reduced risk.

Authors:  S Shiffman; J L Pillitteri; S L Burton; M E Di Marino
Journal:  Tob Control       Date:  2004-03       Impact factor: 7.552

4.  Preliminary investigation of the advertising and availability of PREPs, the new "safe" tobacco products.

Authors:  Norval Hickman; Elizabeth A Klonoff; Hope Landrine; Kennon Kashima; Bina Parekh; Senaida Fernandez; Kamala Thomas; Catherine Brouillard; Michele Zolezzi; Jennifer Jensen; Zorahna Weslowski
Journal:  J Behav Med       Date:  2004-08

5.  Cigarette smoking among adults--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-05-27       Impact factor: 17.586

6.  Smoker awareness of and beliefs about supposedly less-harmful tobacco products.

Authors:  Richard J O'Connor; Andrew Hyland; Gary A Giovino; Geoffrey T Fong; K Michael Cummings
Journal:  Am J Prev Med       Date:  2005-08       Impact factor: 5.043

7.  Glass fiber contamination of cigarette filters: an additional health risk to the smoker?

Authors:  J L Pauly; H J Lee; E L Hurley; K M Cummings; J D Lesses; R J Streck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-11       Impact factor: 4.254

8.  Tobacco harm reduction: what do the experts think?

Authors:  E G Martin; K E Warner; P M Lantz
Journal:  Tob Control       Date:  2004-06       Impact factor: 7.552

9.  Community tobacco control leaders' perceptions of harm reduction.

Authors:  A M Joseph; D Hennrikus; M J Thoele; R Krueger; D Hatsukami
Journal:  Tob Control       Date:  2004-06       Impact factor: 7.552

10.  Nicotine availability from Eclipse tobacco-heating cigarette.

Authors:  J A Stapleton; M A Russell; G Sutherland; C Feyerabend
Journal:  Psychopharmacology (Berl)       Date:  1998-10       Impact factor: 4.530

View more
  19 in total

1.  A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects.

Authors:  Andrea R Vansickel; Caroline O Cobb; Michael F Weaver; Thomas E Eissenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit.

Authors:  Matthew J Carpenter; Kevin M Gray
Journal:  Nicotine Tob Res       Date:  2010-01-06       Impact factor: 4.244

Review 3.  Postmarketing surveillance for "modified-risk" tobacco products.

Authors:  Richard J O'Connor
Journal:  Nicotine Tob Res       Date:  2011-01-20       Impact factor: 4.244

Review 4.  Asian herbal-tobacco cigarettes: "not medicine but less harmful"?

Authors:  Aiyin Chen; Stanton Glantz; Elisa Tong
Journal:  Tob Control       Date:  2007-04       Impact factor: 7.552

5.  Expanding clinical laboratory tobacco product evaluation methods to loose-leaf tobacco vaporizers.

Authors:  Alexa A Lopez; Marzena Hiler; Sarah Maloney; Thomas Eissenberg; Alison B Breland
Journal:  Drug Alcohol Depend       Date:  2016-10-11       Impact factor: 4.492

Review 6.  Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

Authors:  Richard J O'Connor; K Michael Cummings; Vaughan W Rees; Gregory N Connolly; Kaila J Norton; David Sweanor; Mark Parascandola; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 7.  Assessing consumer responses to potential reduced-exposure tobacco products: a review of tobacco industry and independent research methods.

Authors:  Vaughan W Rees; Jennifer M Kreslake; K Michael Cummings; Richard J O'Connor; Dorothy K Hatsukami; Mark Parascandola; Peter G Shields; Gregory N Connolly
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

8.  Tobacco industry control of menthol in cigarettes and targeting of adolescents and young adults.

Authors:  Jennifer M Kreslake; Geoffrey Ferris Wayne; Hillel R Alpert; Howard K Koh; Gregory N Connolly
Journal:  Am J Public Health       Date:  2008-07-16       Impact factor: 9.308

9.  Oral Nicotine Self-Administration in Rodents.

Authors:  Allan C Collins; Sakire Pogun; Tanseli Nesil; Lutfiye Kanit
Journal:  J Addict Res Ther       Date:  2012-06-01

10.  Surveillance indicators for potential reduced exposure products (PREPs): developing survey items to measure awareness.

Authors:  Karen Bogen; Lois Biener; Catherine A Garrett; Jane Allen; K Michael Cummings; Anne Hartman; Stephen Marcus; Ann McNeill; Richard J O'Connor; Mark Parascandola; Linda Pederson
Journal:  Harm Reduct J       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.